Editor's Note:
The month of August was blanketed with developments in the realm of artificial intelligence. Its integration into clinical routines is rapidly increasing, but new research on the way algorithms are tested is calling the safety of clinical AI into question. One study recently revealed that nearly half of FDA cleared AI devices are not validated on patients. As the list of approved algorithms continues to grow, so too will the calls for more stringent surveillance on their impact to patient safety, authors of the study suggested. This is especially true for the field of radiology, as around two-thirds of FDA cleared AI products were developed for use in imaging.
We will continue to follow these and other developments in the field as they unfold. As always, thanks for reading. -Hannah Murphy, Editor
Editor's Note:
The month of August was blanketed with developments in the realm of artificial intelligence. Its integration into clinical routines is rapidly increasing, but new research on the way algorithms are tested is calling the safety of clinical AI into question. One study recently revealed that nearly half of FDA cleared AI devices are not validated on patients. As the list of approved algorithms continues to grow, so too will the calls for more stringent surveillance on their impact to patient safety, authors of the study suggested. This is especially true for the field of radiology, as around two-thirds of FDA cleared AI products were developed for use in imaging.We will continue to follow these and other developments in the field as they unfold. As always, thanks for reading. -Hannah Murphy, Editor